 |
|
|
|
|
Washington Life Science Industry Directory
Target your advertising by state, region or nationwide for the same low rate
Banner Advertising | Event Advertising
Cerevast Therapeutics, Inc.
| | | | | Phone: | (425) 821-1939 | | Fax: | (425) 821-9313 | | Year Established: | 2009 | | Main Contact: | Bradford A. Zakes, President & CEO | | | | Other Contacts: | Andrew Leo, VP, Quality
Anthony J. Alleman, COO
Patrick Bobbitt, VP, Clinical Affairs
Anthony J. Alleman, VP, Operations
Gordon Brandt, M.D., CMO
Kendall Stever, CFO
Andrew Leo, VP, Quality
Mike Rothmeyer, Senior VP, Global Sales and Marketing
Gordon Brandt, M.D, CMO
Andrew Leo, VP, Quality
Mark Moehring, Ph.D., CTO
W.J. Tyler, Ph.D., CSO
Anthony J. Alleman, COO
| | | | Company Description | | Cerevast Therapeutics is a medical technology company with primary emphasis in the field of SonoLysis for the treatment acute ischemic stroke and other vascular disorders. This non-invasive treatment is administered with Cerevast’s proprietary ultrasonic headframe called the ClotBustTM-ER, an operator independent device that can be rapidly and easily deployed by virtually any emergency room staff to safely administer the ultrasound energy for SonoLysis therapy. | |
|
|
|
|
|
|
|
